LEP and irritable bowel syndrome: The authors have suggested that luminal leptin may serve in inflamed colonic samples from UC patients to diffuse inflammation by acting, like other proinflammatory cytokines, to activate nuclear transcription factors NF-κB and AP-1, which are implicated in the pathogenesis of IBD.